Pyrogen Testing Market Is Driven By Rising Demand For Therapeutic Drugs Till 2025: Grand View Research, Inc.

“Grand View Research, Inc. – Market Research And Consulting.”
The global pyrogen testing market is expected to reach a value of USD 1.9 billion by 2025, according to report by Grand View Research, Inc. Increasing demand for therapeutic drugs including pharmaceuticals, biopharmaceuticals, and biologics is the major factor that propels growth of the market during forecast period.

According to a report by Grand View Research, Inc., global pyrogen testing market is anticipated to value USD 1.9 billion by 2025. Growing need for therapeutic drugs including biopharmaceuticals, pharmaceuticals, and biologics can propel demand for pyrogen testing products. Pyrogen is expected to be toxic molecular substance, which can lead to fever if induced in human body or animal.

Rising cases of chronic disorders owing to unhealthy lifestyle is predicted to surge demand for pyrogen testing products. Smoking, lack of exercise, alcohol consumption can cause chronic disorders in humans including diabetes, cardiovascular disorders, cancer, and respiratory problems. This, in turn can fuel demand for medical devices and therapeutic drugs to treat these health problems. Increasing use of pyrogen tests to ensure quality of drugs and devices being used in treatment of chronic disorders can augment market growth during the forecast period (2014 to 2025).

Full Research Report On Pyrogen Testing Market Analysis: 
www.grandviewresearch.com/industry-analysis/pyrogen-testing-market

U.S. pyrogen testing market, by product, 2014 – 2025 (USD Million)

 

U.S. pyrogen testing market, by product, 2014 - 2025 (USD Million)

The pyrogen testing market can be segregated on the basis of product, test-type, end-use, and region. Based on product, the market can be categorized into instruments, services, and consumables. Consumables segment dominated the market and accounted for maximum revenue share in 2016. Increasing cases of chronic disorders can drive production of medical devices products, biologics, and pharmaceuticals. This, in turn can spur demand for pyrogen testing consumables including reagents and kits.

Similarly, instruments segment is predicted to witness substantial growth in near future attributed to technical improvements in these products. Rising demand for medical devices to for diagnosis and treatment of chronic diseases can stimulate market growth.

Based on test type, the market can be classified into chromogenic test, turbidimetric test, gel clot test, in-vitro pyrogen test, rabbit test, and LAL test. LAL test segment is projected to grow fast in coming years owing to rising need for animal-free detection tests.

Browse More Reports Of This Category By Grand View Research At: 
www.grandviewresearch.com/industry/biotechnology

North America pyrogen testing market share, by end-use, 2016 (%)

North America pyrogen testing market share, by end-use, 2016 (%) 

On the contrary, rabbit pyrogen test is expected to be popular in past years. However, growing popularity of animal-free tests can restrict growth of segment over the forecast period. Ability of animal-free tests to evaluate the product and not damaging any living organisms can fuel demand for such tests in near future.

Based on end-use, the market can be divided into, pharmaceutical and biotechnology companies, medical devices companies, and others. In 2016, pharmaceutical and biotechnology companies segment dominated the market and accounted for highest market share. Increasing production of biopharmaceuticals, pharmaceutical, and other bio products can fuel growth of segment. Rising demand for pyrogen testing instruments and consumables in these companies can further stimulate growth.

On the contrary, medical devices companies segment is likely to grow well during the forecast period. Growing need for advanced medical devices for diagnostic and therapeutic applications and fuel growth of segment in coming years.

Regional segmentation includes Asia Pacific, Europe, North America, Latin America, and Middle East & Africa. In 2016, North America dominated the market and accounted for largest market share. Existence of big biopharmaceutical and biotechnology companies including Merck Group, F. Hoffmann-La Roche AG, and Celgene Corporation in the region can fuel market growth. Continual technological advancements in healthcare infrastructure and launch of new drugs can stimulate growth of market in coming years.

In Asia Pacific, the market is predicted to witness significant growth over the forecast period. Rising penetration of manufacturing companies in countries including India and China to discover drugs can augment growth. In addition, shifting focus of clinical research companies towards Asian countries to perform clinical trials can boost growth of market in the region. Prevalence of strict government policies discovery of new drugs in the region can further impel market growth over the forecast period.

In Europe, the market is predicted to do well in coming years attributed to increasing R&D investment in pharmaceutical sector. This, in turn can increase need for pyrogen testing products to check quality of drugs.

Some of the leading companies offering pyrogen testing are Merck KGaA, Lonza, GenScript, Hyglos GmbH, and Pyrostar. Most companies are expected to adopt business strategies including mergers and acquisitions to maintain competitive edge. In addition, companies can also invest in R&D activities to develop innovative new products matching consumer demand.

Grand View Research has segmented the pyrogen testing market on the basis of product, test type, end-use, and region:

Pyrogen Testing Product Outlook (Revenue, USD Million; 2014 – 2025)

  • Consumables

  • Instruments

  • Services

Pyrogen Testing Test Type Outlook (Revenue, USD Million; 2014 – 2025)

  • LAL test

  • Chromogenic test

  • Turbidimetric test

  • Gel clot test

  • In vitro pyrogen test         

  • Rabbit test

Pyrogen Testing End-Use Outlook (Revenue, USD Million; 2014 – 2025)

  • Pharmaceutical and biotechnology companies

  • Medical devices companies

  • Others

Pyrogen Testing Regional Outlook (Revenue, USD Million; 2014 – 2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

  • Asia Pacific

    • Japan

    • China

    • India

  • Latin America

    • Brazil

    • Mexico

  • MEA

    • South Africa

Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com/

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: www.grandviewresearch.com/industry-analysis/pyrogen-testing-market